🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an efficacy and safety study to compare aprepitant with ondansetron...
Status
Completed
Location
Multiple Locations
Start Date
2012-12-12
Trial ID
NCT01636947
This study is being done to determine the efficacies of two preventative dr...
Status
Completed
Location
The Ohio State University Wexner Medical Center
Start Date
2007-06
Trial ID
NCT01474915
Treatments Being Tested
The goal of this clinical trial is to learn if medroxyprogesterone acetate ...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Xinxiang Medical University
Start Date
2025-08-10
Trial ID
NCT07124195
Bariatric surgery remains the most effective therapy for obesity. Postopera...
Status
Completed
Location
Stony Brook University Hospital
Start Date
2017-08-28
Trial ID
NCT03435003
The purpose of this study was to determine the appropriate dosing regimen o...
Status
Completed
Location
Multiple Locations
Start Date
2012-12-13
Trial ID
NCT01697579
Treatments Being Tested
Chemotherapy-induced nausea and vomiting is a common side effect of cancer ...
Status
Completed
Location
Fifth Affilliated Hospital of Sun Yat-sen University
Start Date
2020-02-03
Trial ID
NCT04437017
Treatments Being Tested
Olanzapine is frequently used off-label as an adjunct antiemetic in clinica...
Status
Completed
Location
Hôpital Charles-LeMoyne
Start Date
2019-04-29
Trial ID
NCT04075955
Treatments Being Tested
The purpose of the study is to assess the effect of Emend (aprepitant) on n...
Status
Completed
Location
University of Illinois Medical Center
Start Date
2005-11
Trial ID
NCT00711555
Treatments Being Tested
The objective of this study is to investigate the efficacy of olanzapine as...
Status
Terminated
Location
University of Michigan Rogel Cancer Center
Start Date
2020-12-28
Trial ID
NCT04503668
Treatments Being Tested
This is a multicenter, randomized, controlled, double-blind, phase III stud...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2020-10-01
Trial ID
NCT04536558